You are here: Industry Insights > Holmusk

News List

Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs prnasia
July 08, 2021
Otsuka Pharmaceutical Development & Commercialization, Inc., announces today that it has entered a three-year collaboration with Holmusk Inc., a global data science and digital health company building the world's largest real-world evidence (RWE) ...
Holmusk Acquires Mental Health Analytics Provider Otsuka Health Solutions to Expand its Footprint in the UK prnasia
April 27, 2021
Holmusk, a leading global data science and digital health company building the world's largest Real-World Evidence (RWE) platform for behavioral health, announced today that it has acquired Otsuka Health Solutions (OHS), a UK-based mental health ...
Holmusk, National Healthcare Group and Institute of Mental Health outline strategic collaboration to strengthen mental healthcare in Singapore prnasia
January 13, 2021
Holmusk has signed a Memorandum of Understanding (MOU) with Singapore's National Healthcare Group (NHG) and the Institute of Mental Health (IMH), to jointly develop innovative solutions for mental healthcare.
Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific prnasia
November 11, 2020
Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
Holmusk and NHCS Extend Collaboration to Improve Heart Disease Care prnasia
December 25, 2019
The past 3 years of collaboration have resulted in multiple positive outcomes, for research and better patient care. One success was the use of Holmusk's proprietary analytics methodology to predict the risk of secondary major adverse cardiovascular event
Holmusk secures $9.75 M in Pre-Series A financing biospectrumasia
October 25, 2018
The funds allow Holmusk to expand its footprint in USA and Europe.Image credit- marsdd.com Holmusk, a Singapore-headquartered digital health and data analytics company with a global presence, recently announced closing of $9.75 million in Pre-Series A
Holmusk: Using Data to Improve Clinical Outcomes for Cardiovascular Disease in Singapore en-cphi.cn
April 07, 2017
Holmusk, a global digital health and data analytics company -- has embarked on a three-year partnership with National Heart Centre Singapore (NHCS) to improve care for heart failure and coronary artery disease using big data analytics.